Page 5 - Primary Immunodeficiency News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Primary immunodeficiency. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Primary Immunodeficiency Today - Breaking & Trending Today

Takeda: HYQVIA Gets FDA Approval To Treat Primary Immunodeficiency In Children

Japan's Takeda Pharmaceutical Co. Ltd. (TAK, TKPHF.PK) announced Tuesday that the U.S. Food and Drug Administration has approved a supplemental biologics license application or sBLA to expand the use of HYQVIA to treat primary immunodeficiency or PI in children 2-16 years old. ....

More Such Health News , Japan Takeda Pharmaceutical Co , Drug Administration , Takeda Pharmaceutical , Derived Therapies Business Unit , Fda Approval , Primary Immunodeficiency , Takeda Hyqvia ,